These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder. Broede A; Oll M; Maurer A; Siegert S; Stoerkel S; Golz R; Schwamborn K; Veeck J; Knuechel R; Gaisa NT; J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756 [TBL] [Abstract][Full Text] [Related]
24. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741 [TBL] [Abstract][Full Text] [Related]
25. Problems arising in the diagnosis of primary ovarian transitional cell carcinoma after the occurrence of a transitional cell carcinoma of the bladder: a report of a difficult case and a critical review of literature. Raspollini MR; Paglierani M; Taddei GL Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):178-83. PubMed ID: 19521281 [TBL] [Abstract][Full Text] [Related]
26. [Bladder tumor histoseminar - Case 7: Primary urothelial adenocarcinoma]. Lindner V Ann Pathol; 2016 Dec; 36(6):398-403. PubMed ID: 27865515 [No Abstract] [Full Text] [Related]
27. Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. Lacy S; Lopez-Beltran A; MacLennan GT; Foster SR; Montironi R; Cheng L Anal Quant Cytol Histol; 2009 Feb; 31(1):5-16. PubMed ID: 19320188 [TBL] [Abstract][Full Text] [Related]
28. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma. Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic pitfalls of rare urinary bladder tumors: differential diagnosis of lymphoma-like carcinoma of the bladder--a clinicopathologic study and literature review. Wronski S; Marszalek A J Clin Oncol; 2011 Mar; 29(8):e196-9. PubMed ID: 21189383 [No Abstract] [Full Text] [Related]
30. Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates. Solomon JP; Hansel DE Adv Anat Pathol; 2015 Mar; 22(2):102-12. PubMed ID: 25664945 [TBL] [Abstract][Full Text] [Related]
31. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Gordetsky J; Epstein JI Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758 [TBL] [Abstract][Full Text] [Related]
32. Novel markers of squamous differentiation in the urinary bladder. Huang W; Williamson SR; Rao Q; Lopez-Beltran A; Montironi R; Eble JN; Grignon DJ; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Hahn NM; Wang M; Koch MO; Cheng L Hum Pathol; 2013 Oct; 44(10):1989-97. PubMed ID: 23806524 [TBL] [Abstract][Full Text] [Related]
33. [Bladder tumor histoseminar - Introduction. Bladder tumours diagnosis facing new treatments and new molecular classifications]. Allory Y Ann Pathol; 2016 Dec; 36(6):371-372. PubMed ID: 27838083 [No Abstract] [Full Text] [Related]
34. Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder. Adam RM; DeGraff DJ Urol Oncol; 2015 Oct; 33(10):444-50. PubMed ID: 26254697 [TBL] [Abstract][Full Text] [Related]
35. Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach? Molina-Cerrillo J; Martínez-Sáez O; Alonso-Gordoa T; Tirado-Zambrano P; Delgado-Vargas B; Earl J; Grande E Clin Genitourin Cancer; 2015 Dec; 13(6):493-8. PubMed ID: 26027772 [TBL] [Abstract][Full Text] [Related]
36. Molecular biomarkers in urothelial bladder cancer. Kim WJ; Bae SC Cancer Sci; 2008 Apr; 99(4):646-52. PubMed ID: 18377416 [TBL] [Abstract][Full Text] [Related]
37. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy. Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356 [TBL] [Abstract][Full Text] [Related]
38. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer. Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769 [TBL] [Abstract][Full Text] [Related]
39. [Non-urothelial tumors of the urinary tract]. Mikuz G Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278 [TBL] [Abstract][Full Text] [Related]
40. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Helpap B Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]